An Evaluation of Statistical Methods for Analyzing Follow-Up Gaussian Laboratory Data with a Lower Quantification Limit

REFERENCES

• Baeten, J. M., Kahle, E., Lingappa, J. R., Coombs, R. W., Delany-Moretlwe, S., Nakku-Joloba, E., Mugo, N. R., Wald, A., Corey, L., Donnell, D., Campbell, M. S., Mullins, J. I., Celum, C., the Partners in Prevention HSV/HIV Transmission Study Team. (2011). Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Science Translational Medicine 3:77ra29.
   Google Scholar
• Chu, H., Nie, L., Cole, S. R. (2006). Sample size and statistical power assessing the effect of interventions in the context of mixture distributions with detection limits. Statistics in Medicine 25:2647–2657.
   PubMed Web of Science ®Google Scholar
• Dunne, E. F., Whitehead, S., Sternberg, M., Thep-Amnuay, S., Leelawiwat, W., McNicholl, J. M., Sumanapun, S., Tappero, J. W., Siriprapasiri, T., Markowitz, L. (2008). Suppressive acyclovir therapy reduces HIV cervericovaginal shedding in HIV-1 and HSV-2-infected women, Chiang Rai, Thailand. JAIDS 49:77–83.
   Google Scholar
• Farewell, V. T. (1983). The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 3:1041–1046
   Google Scholar
• Fedorov, V., Mannino, F., Zhang, R. (2009). Consequences of dichotomization. Pharmaceutical Statistics 8:50–61.
   PubMed Web of Science ®Google Scholar
• Gehan, E. A. (1965). A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:205–223.
   Google Scholar
• Hughes, J. P. (1999). Mixed effects models with censored data with application to HIV RNA levels. Biometrics 55:625–639.
   PubMed Web of Science ®Google Scholar
• Journot, V., Chene, G., Joy, P., Saves, M., Jacqmin-Gadda, H., Molina, J.-M., Salamon, R., the ALBI Study Group. (2001). Viral load as a primary outcome in human immunodeficiency virus trials: a review of statistical analysis methods. Controlled Clinical Trials 22:639–658.
   PubMedGoogle Scholar
• Lachenbruch, P. A. (2001) Comparisons of two-part models with competitors. Statistics in Medicine 20:1215–1234.
   PubMed Web of Science ®Google Scholar
• Lubin, J. H., Colt, J. S., Camann, D., Davis, S., Cerham, J. R., Seerson, R. K., Bernstein, L., Hartge, P. (2004). Epidemiologic evaluation of measurement data in the presence of detection limits. Environmental Health Perspectives 112:1691–1696.
   PubMed Web of Science ®Google Scholar
• Lyles, R. H., Lyles, C. M., Taylor, D. J. (2000). Random regression models for human immunodeficiency virus ribonucleic acid data subject to left censoring and informative drop-outs. Applied Statistics 49:485–497.
   Web of Science ®Google Scholar
• Lynn, H.S. (2001). Maximum likelihood inference for left-censored HIV RNA data. Statistics in Medicine 20:33–45.
   PubMed Web of Science ®Google Scholar
• McLean, C., van de Wijgert, J. H. H. M., Jones, H. E., Karon, J. M., McNicoll, J. M., Whitehead, S. J., Braunstein, S., Achalapong, J., Chaikummao, S., Tappero, J. W., Markowitz, L. E., Kilmarx, P. H. (2010). HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand. AIDS 24:717–722.
   PubMed Web of Science ®Google Scholar
• Molina, J.-M., Andrade-Villaneuva, J., Chevarria, J., Chetotisakd, P., Corral, J., David, N., Moyle, G., Mancini, M., Percial, L., Yang, R., Thiry, A., McGrath, D., for the CASTLE Study Team. (2008). One-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naïve HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. The Lancet 372:646–655.
   PubMed Web of Science ®Google Scholar
• Moulton, L. H., Curriero, F. C., Barroso, P. F. (2002). Mixture models for quantitative HIV RNA data. Statistical Methods in Medical Research 11:317–325.
   PubMed Web of Science ®Google Scholar
• Nie, L., Chu, H., Cheng, Y., Spurney, C., Nagaraju, K., Chen, J. (2009). Marginal and conditional approaches to multivariate variables subject to limit of detection. Journal of Biopharmaceutical Statistics 19:1151–1161.
   PubMed Web of Science ®Google Scholar
• Randles, R. H., Wolfe, D. A. (1979). Introduction to the Theory of Nonparametric Statistics. New York, NY: John Wiley & Sons.
   Google Scholar
• Schouten, H., Kester, A. (2010). A simple analysis of a simple crossover trial with a dichotomous outcome measure. Statistics in Medicine 29:193–198.
   PubMed Web of Science ®Google Scholar
• Senn, S. (2002). Cross-over Trials in Clinical Research, 2nd ed. Chichester, England: John Wiley & Sons.
   Google Scholar
• Senn, S. (2003). Disappointing dichotomies. Pharmaceutical Statistics 2:239–240.
   Web of Science ®Google Scholar
• Senn, S., Holford, N., Hockey, H. (2012). The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation. Statistics in Medicine 31:4380–4295. doi:10.1002/sim5515.
   Web of Science ®Google Scholar
• Thiebaut, R., Jacqmin-Gadda, H. (2004). Mixed models for longitudinal left-censored repeated measures. Computer Methods and Programs in Biomedicine 74:255–260.
   PubMed Web of Science ®Google Scholar
• Thiebaut, R., Jacqmin-Gadda, H. (2007). Corrigendom to “Mixed models for longitudinal left-censored repeated measures”. Computer Methods and Programs in Biomedicine 87:78–79.
   Web of Science ®Google Scholar
• Wiegand, R. E., Rose, C. E., Karon, J. M. (2014). Comparison of methods for analyzing two-group, cross-sectional data with an outcome subject to a detection limit. Statistical Methods in Medical Research. doi:10.1177/0962280214531684.
   Google Scholar